Firm Urged Federal Action on Nicotine Limits
The 22nd Century Group petitioned the FDA to finalize a rule that would drastically cut nicotine levels in cigarettes.
Updated on Sept. 24, 2026 in Substance Abuse
Live Poll
Should federal regulators prioritize implementing a mandatory nicotine reduction standard for cigarettes?
The 22nd Century Group has formally requested that federal policymakers finalize a proposed rule to cap nicotine levels in tobacco products. The move follows years of regulatory delay since the FDA first announced its intent to explore a national nicotine standard in 2018.
Why it matters
The company argues that implementing a maximum nicotine limit is the most effective tool available to curb tobacco-related mortality across the country. Current models suggest that such a standard could eventually prevent millions of young Americans from beginning to smoke.
Federal modeling suggests that capping nicotine at 0.70 milligrams per gram would prevent 48 million young people from starting to smoke by 2100. These projections compare the potential policy impact against historical trends in tobacco initiation and mortality.
The players
22nd Century Group
A biotechnology company that uses plant-science technology to produce VLN cigarettes with reduced nicotine content.
FDA
The federal agency responsible for regulating tobacco products and assessing potential public health impacts of new tobacco standards.
The details
The proposed rule would mandate a 95% reduction in nicotine content compared to traditional cigarettes, effectively rendering the products minimally addictive. The 22nd Century Group, which operates a 60,000 square foot production facility in Mocksville, North Carolina, utilizes patented botanical technology to regulate alkaloid biosynthesis in their plants. By genetically suppressing nicotine production, the company produces cigarettes that contain substantially less of the chemical responsible for tobacco dependence.
Timeline
March 16, 2018: The FDA issued an advance notice of proposed nicotine rulemaking.
January 15, 2025: The FDA issued the formal proposed nicotine rule.
September 15, 2025: The public comment period for the proposed rule closed.
May 2026: The FDA opened a public docket for VLN cigarette renewal applications.
September 24, 2026: 22nd Century Group issued an official call for rule implementation.
Health Landscape
This policy development sits at the intersection of long-standing FDA tobacco control efforts and emerging biotechnology in product manufacturing. It follows years of federal rulemaking attempts aimed at shifting the tobacco market toward non-addictive, lower-nicotine alternatives.
If you are concerned about tobacco dependence, it is worth discussing the potential role of reduced-nicotine products with your doctor. Understanding how different tobacco standards may eventually shift the market can help inform your long-term health and cessation goals.
The takeaway
The primary insight is that national nicotine standards could fundamentally alter the trajectory of tobacco addiction in the U.S. population. Readers should continue to consult with medical professionals about evidence-based smoking cessation methods while monitoring federal policy updates.
Further reading
For more on the regulatory and health impacts of these products, visit Substance Abuse.
Live Poll
Should federal regulators prioritize implementing a mandatory nicotine reduction standard for cigarettes?
